BS en 12683 - 1998
BS en 12683 - 1998
BS en 12683 - 1998
| BS EN
|
|
|
12683:1998
|
|
|
|
|
|
|
|
|
|
|
|
|
Biotechnology Ð Modified |
|
|
|
organisms for application in |
|
|
|
|
the environment Ð Guidance |
|
|
|
for the characterization of the |
|
|
|
|
genetically modified organism |
|
|
|
by analysis of the molecular |
|
|
|
--`,`,-`-`,,`,,`,`,,`---
|
stability of the genomic |
|
|
|
modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The European Standard EN 12683:1998 has the status of a |
British Standard |
|
|
|
|
|
|
|
|
ICS 07.080; |
|
|
|
|
|
|
|
|
NO COPYING WITHOUT BSI PERMISSION EXCEPT AS PERMITTED BY COPYRIGHT LAW
|
|
|
|
Copyright British Standards Institution
Provided by IHS under license with BSI
No reproduction or networking permitted without license from IHS Not for Resale
BS EN 12683:1998
National foreword
This British Standard is the English language version of EN 12683:1998.
The UK participation in its preparation was entrusted to Technical Committee
CII/58, Biotechnology, which has the responsibility to:
Summary of pages
This document comprises a front cover, an inside front cover, the EN title page,
pages 2 to 8, an inside back cover and a back cover.
BSI 1998
--`,`,-`-`,,`,,`,`,,`---
ICS 07.080
Descriptors: biotechnology, genetics, modified organisms, environments, environmental protection, analysis method, bioassay,
experimental design
English version
CEN
European Committee for Standardization
Comite EuropeÂen de Normalisation
EuropaÈisches Komitee fuÈr Normung
1998 CEN All rights of exploitation in any form and by any means reserved worldwide for CEN national
Members.
Ref. No. EN 12683:1998 E
--`,`,-`-`,,`,,`,`,,`---
Foreword Contents
This European Standard has been prepared by Page
Technical Committee CEN/TC 233, Biotechnology, the
Secretariat of which is held by AFNOR. Foreword 2
This European Standard shall be given the status of a Introduction 3
national standard, either by publication of an identical 1 Scope 3
text or by endorsement, at the latest by January 1999, 2 Normative references 3
and conflicting national standards shall be withdrawn
at the latest by January 1999. 3 Definitions 3
This European Standard has been prepared under a 4 Molecular stability testing 4
mandate given to CEN by the European Commission 5 Materials 5
and the European Free Trade Association.
6 Considerations for experimental
According to the CEN/CENELEC Internal Regulations, procedures 5
the national standards organizations of the following
countries are bound to implement this European 7 Validity of data analysis 7
Standard: Austria, Belgium, Czech Republic, Denmark, 8 Documentation of results 7
Finland, France, Germany, Greece, Iceland, Ireland, Annex A (informative) Bibliography 8
Italy, Luxembourg, Netherlands, Norway, Portugal,
Spain, Sweden, Switzerland and the United Kingdom.
--`,`,-`-`,,`,,`,`,,`---
Ð gene transfer;
modification with respect to time and/or generation
Ð copy number of accessory genetic elements like
3.10 plasmids;
organism Ð methylation.
biological entity capable of replication or of These factors influence mainly the genomic
transferring genetic material modification, the type of integration into, and/or the
3.11 localization within the genome.
reproducibility Molecular stability of the functional expression can
depend on factors which indirectly influence the
precision under reproducibility conditions [ISO 3534-1] genomic modification such as:
NOTE 1 Reproducibility conditions are conditions where test
results are obtained with the same method on identical test items Ð recipient organism;
in different laboratories with different operators using different Ð tissue and/or organ specificity;
equipment.
Ð dependence upon metabolic activity;
NOTE 2 Results should be expressed as reproducibility standard
deviation or reproducibility coefficient of variation. Ð developmental stage (e.g. germination,
senescence);
4 Molecular stability testing Ð external factors (e.g. wounding, UV- and visible
light, temperature, habitat).
4.1 General considerations Factors which influence the genomic modification can
The relative molecular stability of traits introduced by act either in cis or in trans.
genetic modification, over time and generation, can be Examples for factors acting in cis are:
important in order to ensure the performance of the
GMO under field conditions and/or for biosafety Ð integration site;
reasons. The design of an analysis for molecular Ð chromatin structure;
stability should take into account the natural variations Ð DNA structure;
on the one hand and the experimental objective with
Ð copy number;
respect to product performance and safety on the
other. Ð methylation.
Molecular stability analysis can be performed at either Examples for factors acting in trans are:
the structural or genomic level or at the functional or Ð life cycle;
phenotypic level depending on the objective of Ð heritability;
experiment. Testing for molecular stability between
generations should be carried out over an appropriate Ð external factors.
number of generations. 4.4 Analysis of molecular stability
Molecular stability testing could be required at various 4.4.1 General
points during the development and release of a GMO
into the environment. This generally starts in contained The molecular stability testing is the correlation of
systems, like the laboratory, microcosms, growth analytical data (structure and expression) from GMOs
chambers, greenhouses, animal houses and can or their genetic material between samplings taken at
continue during the release into the environment. different time points.
6.3.3 Molecular analysis For all methods, a positive control should contain
the modified sequence, whose molecular stability is
6.3.3.1 General
being analysed. In the case of Southern
Molecular analysis of the stability of the genetic hybridization, the positive control should be
modification of interest can be performed at various obtained by digestion of the DNA with a restriction
levels, such as the structure of the genome, RNA- enzyme or combination of enzymes having at least
transcription, protein-expression. The various methods two cutting sites in the modified genetic sequence. A
are described in 6.3.3.2 to 6.3.3.5. negative control should be obtained by using the
6.3.3.2 Structural or genomic analysis nucleic acid of an organism which is identical to the
GMO except for the lack of the modified genetic
At this level, nucleic acid hybridization and DNA- or sequence.
RNA-fragment amplification methods can be applied. In
order to avoid misinterpretation of the results b) Nucleic acid amplification methods
appropriate controls should be included in all Various methods can be applied, depending on the
experiments. Methods for analysis structure or type of molecular stability question to be answered
genomic molecular stability include the following. (e.g. PCR, reverse transcriptase-PCR, inverse-PCR).
a) Nucleic acid hybridization methods Nucleic acid amplification methods are very sensitive
Slot/dot blot can be applied, if cultivation of the techniques. Therefore, special care should be given
GMO is not possible or necessary. The advantage of to the purity of the sample, the optimization of the
this method is that a higher number of samples can stringency during the amplification reaction and the
be screened within reasonable time and a more inclusion of appropriate controls. The detection
reasonable cost than with Southern hybridization should be done in such a way that false positive
analysis. However, as a disadvantage, false positive results are excluded. For example, this could include
results can often be obtained from closely-related a Southern analysis or restriction enzyme analysis of
sequences, if the hybridization stringency is not the amplified DNA. Additionally, crude DNA samples
sufficient. sometimes contain components that inhibit the
activity of the polymerase. Control amplification
Colony or plaque hybridization can be applied when reactions using a second pair of primers specific for
the molecular stability of a large number of an additional endogenous DNA sequence should be
micro-organisms has to be analysed. The specificity performed to ensure the purity of the DNA sample.
of the technique depends on the ability of the gene
probe to differentiate between the target sequence 6.3.3.3 Rate of transcription
and cross-reacting sequences. To identify artifacts, it Nuclear-run-on-assays, performed according to
is necessary to use duplicate filters. laboratory manuals (see annex A [7], [8]) can be
Slot/dot blot and colony and plaque hybridization applied to determine the molecular stability of the rate
give no information about the integrity of the of transcription. The following controls should be used:
structure. With these methods, only the presence or Ð a positive control corresponds to a host gene
absence of a certain genomic modification can be which has no homology with the genetic
determined. modification of interest and which is transcribed in
Southern hybridization is characterized by a higher the tissue of interest;
sensitivity and specificity than the previously Ð a negative control corresponds to an assay
described methods. However, as it is time- and performed in the presence of alpha-amanitin which
cost-intensive, generally only a smaller number of acts as an inhibitor of RNA polymerase II.
samples can be handled. The method is very time-consuming and laborious.
Therefore, it is usually used for diagnosis or
verification rather than for screening. The specificity 6.3.3.4 Steady state levels of RNA
of the technique depends mainly on the gene probe Methods to determine the steady state levels of the
used and the nature of the target nucleic acid. This transcribed RNA include RNA slot/dot blot, Northern
method is particularly suitable to detect hybridization, RNase-protection-assays and
rearrangements which can give rise to questions reverse-transcriptase PCR. The following controls
concerning molecular stability or instability of the should be used:
genomic modification. Ð a positive control corresponds to a host gene
Data signals from false positive hybridization are which has no homology with the genetic
recognized if a fragment other than the size modification of interest and which is transcribed in
predicted from the genetic modification of interest is the tissue of interest;
detected by the gene probe. However, in this case it Ð a negative control corresponds to RNA extracted
is also possible that a deletion or insertion has from the non-genetically modified organism.
occurred within the genomic modification. For the
case of hybridization analysis, degradation of nucleic
acid in the samples can also lead to unexpected
hybridization data signals.
--`,`,-`-`,,`,,`,`,,`---
Annex A (informative)
Bibliography
[1] Council Directive 90/219/EEC of 23 April 1990
on the contained use of genetically modified
micro-organisms. OJEC 08.05.1990,
no L 117, p 1.
[2] Council Directive 90/220/EEC of 23 April 1990
on the deliberate release into the environment
of genetically modified organisms. OJEC
08.05.1990, no L 117, p 15.
[3] EN 12468, Biotechnology Ð Modified
organisms for application in the
environment Ð Guidance for the monitoring
strategies for deliberate releases of genetically
modified plants.
[4] EN 12685, Biotechnology Ð Modified
organisms for application in the
environment Ð Guidance for the monitoring
strategies for deliberate releases of genetically
modified micro-organisms, including viruses.
[5] EN 12305, Biotechnology Ð Modified
organisms for application in the
environment Ð Guidance for the sampling
strategies for deliberate releases of genetically
modified plants.
[6] EN 12686, Biotechnology Ð Modified
organisms for application in the
environment Ð Guidance for the sampling
strategies for deliberate releases of genetically
modified micro-organisms, including viruses.
[7] Sambrook J., Fritsch E.F. and Maniatis T.
(1989). Molecular Cloning. A laboratory
manual, Second Edition, Cold Spring Harbor
Laboratory Press.
[8] Ausubel, F.A. et al. (eds. Greene). Current
Protocols in Molecular Biology. Publ. Wiley &
Sons.
--`,`,-`-`,,`,,`,`,,`---
|
|
|
|